Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 OtonomyAytu BiopharmaLiminal BioSciencesAptevo TherapeuticsLeap Therapeutics
SymbolNASDAQ:OTICNASDAQ:AYTUNASDAQ:LMNLNASDAQ:APVONASDAQ:LPTX
Price Information
Current Price$2.21$6.49$4.15$25.32$1.65
52 Week RangeBuyBuyHoldBuyBuy
MarketRank™
Overall Score1.71.41.11.31.5
Analysis Score3.51.53.13.53.5
Community Score2.62.61.82.42.6
Dividend Score0.00.00.00.00.0
Ownership Score1.71.70.00.00.8
Earnings & Valuation Score0.61.30.60.60.6
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$8.30$7.00$18.00$32.00$5.38
% Upside from Price Target275.57% upside7.86% upside333.73% upside26.38% upside225.76% upside
Trade Information
Market Cap$106.79 million$116.06 million$124.27 million$112.65 million$98.44 million
Beta2.31-0.261.877.471.35
Average Volume1,134,697711,982812,00459,443855,307
Sales & Book Value
Annual Revenue$600,000.00$27.63 million$3.70 million$32.42 millionN/A
Price / Sales177.974.2033.593.47N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.31 per share$7.88 per share$3.06 per share$3.66 per share($0.07) per share
Price / Book1.690.821.366.92N/A
Profitability
Net Income$-44,670,000.00$-13,620,000.00$-155,020,000.00$-40,450,000.00$-32,900,000.00
EPS($1.45)N/A($10.94)($15.27)($1.47)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-14,379.87%-32.73%-2,758.32%N/AN/A
Return on Equity (ROE)-108.75%-25.20%-196.39%-345.40%-89.24%
Return on Assets (ROA)-54.62%-13.80%-88.62%-97.13%-70.07%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.20%0.12%2.42%11.44%N/A
Current Ratio8.97%3.04%2.17%4.13%8.70%
Quick Ratio8.97%2.51%1.75%4.13%8.70%
Ownership Information
Institutional Ownership Percentage72.25%89.77%13.45%14.06%41.90%
Insider Ownership Percentage16.10%6.60%N/A10.88%25.89%
Miscellaneous
Employees56753005830
Shares Outstanding48.32 million17.88 million29.94 million4.45 million59.66 million
Next Earnings Date5/6/2021 (Estimated)5/13/2021 (Estimated)5/12/2021 (Estimated)5/12/2021 (Estimated)5/13/2021 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableNot Optionable
SourceHeadline
Flagship Biosciences and Leap Therapeutics Announce Partnership and Approach Using RNAscope and Image Analysis for Patient EnrollmentFlagship Biosciences and Leap Therapeutics Announce Partnership and Approach Using RNAscope and Image Analysis for Patient Enrollment
finance.yahoo.com - April 12 at 8:07 AM
 Brokerages Anticipate Leap Therapeutics, Inc. (NASDAQ:LPTX) Will Announce Quarterly Sales of $390,000.00 Brokerages Anticipate Leap Therapeutics, Inc. (NASDAQ:LPTX) Will Announce Quarterly Sales of $390,000.00
americanbankingnews.com - April 12 at 3:46 AM
Zacks: Brokerages Expect Leap Therapeutics, Inc. (NASDAQ:LPTX) Will Post Earnings of -$0.11 Per ShareZacks: Brokerages Expect Leap Therapeutics, Inc. (NASDAQ:LPTX) Will Post Earnings of -$0.11 Per Share
americanbankingnews.com - April 10 at 6:12 AM
Leap Therapeutics Announces Completion of Enrollment for First-Line Patient Cohort in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Gastric or Gastroesophageal Junction CancerLeap Therapeutics Announces Completion of Enrollment for First-Line Patient Cohort in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Gastric or Gastroesophageal Junction Cancer
finance.yahoo.com - April 1 at 8:05 AM
Leap Therapeutics, Inc. (NASDAQ:LPTX) shares surges 28.42% in a week – but can it keep rising?Leap Therapeutics, Inc. (NASDAQ:LPTX) shares surges 28.42% in a week – but can it keep rising?
marketingsentinel.com - March 26 at 12:05 PM
 Analysts Anticipate Leap Therapeutics, Inc. (NASDAQ:LPTX) Will Post Quarterly Sales of $390,000.00 Analysts Anticipate Leap Therapeutics, Inc. (NASDAQ:LPTX) Will Post Quarterly Sales of $390,000.00
americanbankingnews.com - March 25 at 4:36 AM
LPTX Stock Price Increases Over 25% Pre-Market: Why It HappenedLPTX Stock Price Increases Over 25% Pre-Market: Why It Happened
pulse2.com - March 22 at 2:52 PM
Leap Therapeutics Presents DKN-01 Clinical Data at the Society of Gynecologic Oncology 2021 Annual Meeting on Womens CancerLeap Therapeutics Presents DKN-01 Clinical Data at the Society of Gynecologic Oncology 2021 Annual Meeting on Women's Cancer
finance.yahoo.com - March 22 at 9:50 AM
Introducing Leap Therapeutics (NASDAQ:LPTX), A Stock That Climbed 80% In The Last YearIntroducing Leap Therapeutics (NASDAQ:LPTX), A Stock That Climbed 80% In The Last Year
finance.yahoo.com - March 19 at 11:41 AM
What You Need To Know About Leap Therapeutics, Inc.s (NASDAQ:LPTX) Investor CompositionWhat You Need To Know About Leap Therapeutics, Inc.'s (NASDAQ:LPTX) Investor Composition
finance.yahoo.com - January 19 at 5:42 PM
Leap Therapeutics to Present at 39th Annual J.P. Morgan Healthcare ConferenceLeap Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 9:47 AM
Packers RB AJ Dillon breaks out, but Lambeau Leap a work in progressPackers RB AJ Dillon breaks out, but Lambeau Leap a work in progress
washingtontimes.com - December 28 at 5:41 PM
2 Children Die in Detroit Fire; Mom, 3 Kids Leap to Safety2 Children Die in Detroit Fire; Mom, 3 Kids Leap to Safety
usnews.com - December 25 at 1:40 PM
Leap Trigger Kickstarter Exceeds Goal in First DayLeap Trigger Kickstarter Exceeds Goal in First Day
capsulecomputers.com.au - December 22 at 7:53 AM
Leap TriggerLeap Trigger
bleedingcool.com - December 22 at 12:47 AM
Leap Trigger Gets Full Kickstarter Funding In First DayLeap Trigger Gets Full Kickstarter Funding In First Day
bleedingcool.com - December 22 at 12:47 AM
Leap off fiscal cliff is bad option, but not worstLeap off fiscal cliff is bad option, but not worst
pfie.com - December 19 at 2:16 PM
Kickstarter Campaign Launches for AR Game Leap TriggerKickstarter Campaign Launches for AR Game Leap Trigger
capsulecomputers.com.au - December 18 at 10:50 PM
Production On Fox Dramedy Pilot ‘The Big Leap’ Paused After Positive Covid-19 TestsProduction On Fox Dramedy Pilot ‘The Big Leap’ Paused After Positive Covid-19 Tests
msn.com - December 18 at 5:50 PM
Honey of a fundraiser for Lewis Leap FoundationHoney of a fundraiser for Lewis Leap Foundation
theedinburghreporter.co.uk - December 18 at 7:48 AM
Kona Poké Express Food Trailer Celebrates Grand Opening at Quantum Leap Winery in Orlando This Saturday, December 19Kona Poké Express Food Trailer Celebrates Grand Opening at Quantum Leap Winery in Orlando This Saturday, December 19
restaurantnews.com - December 17 at 3:08 PM
HHS, DOD engage Quantum Leap Research Collaborative in search for effective treatments for the sickest COVID-19 patientsHHS, DOD engage Quantum Leap Research Collaborative in search for effective treatments for the sickest COVID-19 patients
oc-breeze.com - December 17 at 3:08 PM
Kona Poké Express Food Trailer to Open Saturday at Quantum Leap WineryKona Poké Express Food Trailer to Open Saturday at Quantum Leap Winery
qsrmagazine.com - December 17 at 3:08 PM
Wild Leap Brewing Co. announces latest in Alpha Abstraction serisWild Leap Brewing Co. announces latest in Alpha Abstraction seris
gwinnettdailypost.com - December 15 at 8:07 PM
Leap Orbit Launches Convergent Provider Directory With Maryland HIELeap Orbit Launches Convergent Provider Directory With Maryland HIE
us.acrofan.com - December 15 at 10:06 AM
DateCompanyBrokerageAction
4/13/2021OtonomyPiper SandlerBoost Price Target
3/1/2021OtonomyHC WainwrightLower Price Target
11/22/2020OtonomyOppenheimerInitiated Coverage
8/17/2020OtonomyCantor FitzgeraldReiterated Rating
5/29/2020OtonomyCraig HallumInitiated Coverage
3/5/2019OtonomyPiper Jaffray CompaniesReiterated Rating
8/14/2018OtonomySunTrust BanksLower Price Target
11/15/2019Aytu BiopharmaNorthland SecuritiesInitiated Coverage
9/18/2019Aytu BiopharmaLADENBURG THALM/SH SHBoost Price Target
3/26/2021Liminal BioSciencesLeede Jones GabReiterated Rating
1/29/2021Liminal BioSciencesBloom BurtonDowngrade
8/11/2020Liminal BioSciencesEchelon Wealth PartnersReiterated Rating
3/4/2020Aptevo TherapeuticsRoth CapitalReiterated Rating
3/23/2021Leap TherapeuticsRaymond JamesSet Price Target
2/10/2020Leap TherapeuticsRobert W. BairdInitiated Coverage
(Data available from 4/19/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.